Ironwood Pharmaceuticals | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 243.83M 19.91M 2025-06
Agios Pharmaceuticals USD 10.75M 3.11M 2025-06
Almirall EUR 191.9M 185.49M 2025-03
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Amarin USD 25.13M 1.78M 2025-03
Ardelyx USD 97.86M 15.35M 2024-12
Astellas Pharma JPY 410.96B 28.53B 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Charles River Laboratories USD 291.68M 48.42M 2025-06
Exact Sciences USD 562.45M 61.91M 2025-06
Halozyme Therapeutics USD 279.36M 62.9M 2025-06
Incyte USD 1.14B 151.67M 2025-06
Ironwood Pharmaceuticals USD 3.65M 60.36M 2024-09
MacroGenics USD 13.86M 94.98M 2024-12
Moderna USD 18M 1000K 2025-06
Myriad Genetics USD 134.2M 16.7M 2025-03
Pacira USD 125.91M 8.71M 2025-06
PTC Therapeutics USD 163.39M 999.84M 2025-06
Sarepta Therapeutics USD 457.87M 149.43M 2025-06
Takeda JPY 722.01B 50.69B 2025-06
Ultragenyx Pharmaceutical USD 143.49M 32.86M 2025-06


Ironwood Pharmaceuticals Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.